Live Rate
| Open | |
|---|---|
| High | |
| Low | |
| Prev. Close | |
| Lower circuit | |
| Upper circuit | |
| 52w High | |
| 52w Low | |
| P/E Ratio |
Patel Chem Specialities Listing Price
| Exchange | Listing Price | Gain/Loss | % |
|---|---|---|---|
| BSE | ₹110.00 | +₹26.00 | +30.95% |
Patel Chem Specialities Subscription
Last updated on 29-Jul-2025 18:58:04
| Category | Offered | Applied | Times |
|---|---|---|---|
| QIBs | 1329600 | 139971200 | 105.27 |
| HNIs | 998400 | 236244800 | 236.62 |
| bHNI | 665600 | 168083200 | 252.53 |
| sHNI | 332800 | 68161600 | 204.81 |
| Individual | 2331200 | 403596800 | 173.13 |
| Total | 4659200 | 779812800 | 167.37 |
Application-Wise Breakup  | |||
|---|---|---|---|
| Category | Reserved | Applied | Times |
| HNIs (10L+) | 139 | 11923 | 85.78 |
| HNIs (3-10L) | 69 | 13477 | 195.32 |
| Individual | 729 | 126124 | 173.01 |
| QIB Interest Cost Per Share (7 Days) | |||||
|---|---|---|---|---|---|
| @7% ₹11.9 | @8% ₹13.6 | @9% ₹15.3 | @10% ₹17 | @11% ₹18.7 | @12% ₹20.4 |
Patel Chem Specialities Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
| bHNI | 8 | 12800 | 1075200 | 139 |
Patel Chem Specialities Reservation
| Category | Shares Offered | % |
|---|---|---|
| QIB | 1329600 | 26.52% |
| HNI | 998400 | 19.92% |
| INDIVIDUAL | 2331200 | 46.5% |
| Market Maker | 353600 | 7.05% |
| Total | 5012800 | 100% |
Patel Chem Specialities About
IPO Reservation
| Investor Category | Shares Offered | No. of Shares |
|---|---|---|
| Individual | 33.30% | 2331200 |
| BHNI | 9.51% | 665600 |
| SHNI | 4.75% | 332800 |
| QIB | 18.99% | 1329600 |
| Anchor | 28.39% | 1987200 |
| Market Maker | 5.05% | 353600 |
| Total | 100.00% | 7000000 |
IPO Details
| Total Issue Size | 70,00,000 shares (aggregating up to 58.80 Cr) |
| Fresh Issue Size | 70,00,000 shares (aggregating up to 58.80 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,78,70,000 shares |
| Share Holding Post Issue | 2,48,70,000 shares |
| Reserved for Market Maker | 3,53,600 shares |
| Market Maker | Globalworth Securities Limited |
Key Performance Indicators
| KPI | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| ROE | 29.85% | 39.21% | 24.32% |
| ROCE | 36.26% | 45.06% | 32.83% |
| RONW | 29.85% | 39.21% | 24.32% |
| EPS (basic) | 6.1 | 4.5 | 1.7 |
| P/E Pre IPO | 14.21 | ||
| P/E Post IPO | 19.77 |
Financial Details In Crores
| Period Ended | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| Assets | 65.31 | 46.97 | 37.08 |
| Revenue | 105.55 | 82.72 | 69.75 |
| Profit After Tax | 10.57 | 7.66 | 2.89 |
| EBITDA | 15.8 | 12.02 | 5.83 |
| Net Worth | 35.4 | 19.52 | 11.87 |
| Reserves and Surplus | 17.53 | 18.52 | 10.87 |
| Total Borrowing | 14.85 | 15.46 | 11.79 |
Company Overview
Incorporated: 2008
Industry: Pharmaceutical Excipients & Specialty Chemicals
Headquarters: India (Facilities in Ahmedabad-Vatva and Himmatnagar-Talod)
Core Business
PCSL manufactures and exports high-quality pharmaceutical excipients and specialty chemicals used in:
Pharmaceuticals (binders, disintegrants, gelling agents)
Food, Cosmetics, Industrial Applications (thickeners, stabilizers)
Manufacturing Capabilities
Facility Area: 7,000 sq. yards
Annual Capacity: 7,200+ MT
Departments: R&D, Production, Quality Control, Storage, Packaging, Warehousing
Certifications: US-DMF, GMP, and other international standards.
Global Reach
Exports to East Asia, Europe, Middle East, North America, and Southeast Asia.
Key Products
Rheollose®: Sodium CMC (thickening/stabilizing agent).
Disolwell®: Croscarmellose Sodium (super disintegrant for tablets).
Swellcal®: Calcium CMC (pharmaceutical disintegrant).
AmyloTab™: Pregelatinized Starch (tablet disintegration aid).
Workforce
109 employees (as of November 30, 2024).
Strength
Diverse Product Portfolio – Offers a wide range of products/services catering to multiple industries and customer needs.
Experienced Leadership – Backed by a seasoned promoter and skilled management team with strong industry knowledge.
Global Reach – Established presence across international markets, enabling wider customer access and revenue diversification.
Weakness
Raw Material Dependency – Lack of long-term supplier agreements may lead to delays or cost fluctuations in raw material procurement.
Related Party Transactions – Ongoing related party dealings could pose risks to financial transparency and governance.
Geographic Concentration – Heavy reliance on few states and a single country for sourcing increases vulnerability to regional disruptions.
Patel Chem Specialities Latest Announcements
| Date | Subject | Attachment Text |
|---|
Patel Chem Specialities Financial Results
Patel Chem Specialities Lead Manager(s)
Patel Chem Specialities Address
Plot No. 272/4-5,
Phase II, G.I.D.C Industrial Estate,
Vatva Road
Ahmedabad, Gujarat, 382445
Phone: 91- 9712999854
Email: cs@patelchem.com
Website: http://www.patelchem.com/
Patel Chem Specialities Registrar
MUFG Intime India Private Limited (Link Intime)
Link Intime India Private Ltd
C 101, 247 Park,
L.B.S.Marg Vikhroli (West),
Mumbai - 400083